Thalidomide and Prednisone Following Peripheral Stem Cell Transplantation in Treating Patients With Multiple Myeloma

NCT00006890 · clinicaltrials.gov ↗

PHASE2

Phase

COMPLETED

Status

67

Enrollment

NETWORK

Sponsor class

Conditions

Multiple Myeloma and Plasma Cell Neoplasm

Interventions

DRUG: prednisone
DRUG: thalidomide

Sponsor

NCIC Clinical Trials Group